OXCARBAZEPINE
NDC 72888-074, OXCARBAZEPINE, suspension, from Advagen Pharma Ltd.
- Product NDC
- 72888-074
- Status
- Listed
- Labeler
- Advagen Pharma Ltd
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215726
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72888-074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE300 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72888-074-14 | 72888007414 | 1 BOTTLE in 1 CARTON (72888-074-14) / 250 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4ef6a941-a017-40f2-a50a-ab66c43b3347NADAC price for package 72888007414
GET /v1/drugs/nadac/72888007414
Use it
Look up 72888-074 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72888-074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72888-074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.